RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 156 filers reported holding RELAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $204,168 | -33.1% | 24,277 | -0.1% | 0.00% | -100.0% |
Q2 2023 | $305,107 | -24.0% | 24,292 | -0.4% | 0.00% | 0.0% |
Q1 2023 | $401,520 | +10.3% | 24,379 | +0.2% | 0.00% | 0.0% |
Q4 2022 | $364,000 | -33.1% | 24,319 | -0.1% | 0.00% | 0.0% |
Q3 2022 | $544,000 | +34.3% | 24,352 | +0.6% | 0.00% | 0.0% |
Q2 2022 | $405,000 | -72.0% | 24,203 | -50.0% | 0.00% | -66.7% |
Q1 2022 | $1,449,000 | -2.5% | 48,403 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $1,486,000 | -2.6% | 48,403 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $1,526,000 | -13.8% | 48,403 | 0.0% | 0.00% | -25.0% |
Q2 2021 | $1,771,000 | +5.9% | 48,403 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $1,673,000 | – | 48,403 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |